Clive Dix
Directeur Général chez C4X DISCOVERY HOLDINGS PLC
Fortune : 312 339 $ au 30/04/2024
Provenance du réseau au premier degré de Clive Dix
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 14 | |
Medicines Discovery Catapult Ltd.
Medicines Discovery Catapult Ltd. Miscellaneous Commercial ServicesCommercial Services Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.
10
| Private Company | Miscellaneous Commercial Services | 10 |
Carrick Therapeutics Ltd.
Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Carrick Therapeutics Ltd. manufactures cancer therapeutics. The company is headquartered in Dublin, Ireland.
9
| Holding Company | Pharmaceuticals: Major | 9 |
C4X Discovery Ltd.
C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Touchlight Holdings Ltd.
Touchlight Holdings Ltd. Financial ConglomeratesFinance Touchlight Holdings Ltd. is an investment holding British company founded in 2014. The private company is based in London, UK. The company's main function is to hold investments.
3
| Private Company | Financial Conglomerates | 3 |
Touchlight IP Ltd.
Touchlight IP Ltd. Miscellaneous Commercial ServicesCommercial Services Touchlight IP Ltd. was founded in 2014 and engages in leasing intellectual property and related products. The private company is based in London, UK.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Clive Dix via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
University of Oxford | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
University of Cambridge | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
University of Leeds | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Touchlight Genetics Ltd.
Touchlight Genetics Ltd. BiotechnologyHealth Technology Touchlight Genetics Ltd. operates as a biotechnology company. It develops an enzymatic means of DNA scale production addresses the limitations of plasmid DNA and meets the growing demands of DNA revolution. It offers DNA enables therapeutics, direct DNA therapeutics, and DNA nanotechnology. The company was founded by jonny Ohlson in 2008 and is headquartered in Hamptonl, the United Kingdom. | Biotechnology | Founder Director/Board Member Director/Board Member | |
University of Birmingham | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Modern Biosciences Ltd.
Modern Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Part of Istesso Ltd., Modern Biosciences Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in London, UK. The company was founded by Samuel Cameron Williams, Alexander James Stevenson. Samuel Cameron Williams has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Founder | |
Pharminox Ltd
Pharminox Ltd Medical/Nursing ServicesHealth Services Pharminox Ltd develops treatments for cancer therapy. The private company is based in Abingdon, UK. The British company was founded by Neil L. Brown. | Medical/Nursing Services | Chairman Director/Board Member | |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
AVACTA GROUP PLC | Miscellaneous Commercial Services | President Director/Board Member | |
Oxford Science Enterprises PLC
Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Consultant / Advisor Private Equity Investor | |
The University of Manchester | College/University | Doctorate Degree Masters Business Admin | |
GLYCOMIMETICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Carrick Therapeutics UK Ltd.
Carrick Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Carrick Therapeutics Ltd., Carrick Therapeutics UK Ltd. is a clinical-stage biopharmaceutical company based in Oxford, UK. Carrick Therapeutics translates in-house and in-licensed assets to target the most aggressive and resistant forms of cancer, working in combination with existing oncology drugs to address unmet patient needs. The British company focuses on developing innovative therapies to improve patient outcomes in oncological therapy. The company's therapies have potential in advanced breast, prostate, and ovarian cancers, with further potential in pancreatic and Ewing's sarcoma. Timothy R. Pearson has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Chief Executive Officer Chairman | |
Pulmagen Therapeutics LLP
Pulmagen Therapeutics LLP Pharmaceuticals: MajorHealth Technology Pulmagen Therapeutics Ltd. manufactures and develops respiratory drugs. Its services include pulmagen respiratory product pipeline, pulmagen crth2 antagonist product pipeline, new generation bronchodilators-astrazeneca collaboration, theocort-inhaled corticosteroid re-sensitisation, inhaled ppar gamma agonists and chiesi collaboration-anti-inflammatory agents. The company was founded in February 2010 and is headquartered in Slough, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
EVOTEC SE | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
RSA Consulting Ltd.
RSA Consulting Ltd. Personnel ServicesCommercial Services RSA Consulting Ltd. provides recruitment services. It also provides services like business planning, process realignment, user requirement specification, systems implementation, and market entry. The company was founded in 1981 and is headquartered in Hatfield, the United Kingdom. | Personnel Services | Chief Executive Officer Director/Board Member | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
IP GROUP PLC | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Aleta Biotherapeutics, Inc.
Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aleta Biotherapeutics, Inc. engages in the immuno-oncology service that focuses on transforming cellular therapeutics. It allows broad spectrum of cancer indication to be targeted including currently intractable solid tumors. The company was founded by Paul Rennert and Roy Lobb and is headquartered in Natick, MA. | Miscellaneous Commercial Services | Director/Board Member | |
CORBUS PHARMACEUTICALS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Syneos Health NC LLC
Syneos Health NC LLC Miscellaneous Commercial ServicesCommercial Services Syneos Health LLC operates therapeutically focused global contract research organization. It provides pharma and biotech services. The firm specializes in the hematology, immunology and inflammation infectious diseases, oncology, ophthalmology, cardiovascular, CNS analgesia, CNS neurology, CNS psychiatry, endocrinology, and gastroenterology and hepatology. The company was founded by Kenneth A. Selzer in 1985 and is headquartered in Raleigh, NC. | Miscellaneous Commercial Services | Chief Executive Officer | |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Analyst | |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Pharmaceuticals: Major | Director/Board Member | |
Draupnir Bio ApS
Draupnir Bio ApS Pharmaceuticals: MajorHealth Technology Draupnir Bio ApS engages in the manufacture and distribution of biotechnological and pharmaceutical products. It also provides medical research services. The company was founded on April 4, 2017 and is headquartered in Risskov, Denmark. | Pharmaceuticals: Major | Chairman | |
Droia Ventures | Corporate Officer/Principal | ||
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | Investment Managers | Consultant / Advisor | |
ALMIRALL, S.A. | Pharmaceuticals: Major | Director/Board Member | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member | |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
Vertex Pharmaceuticals (Europe) Ltd.
Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Vertex Pharmaceuticals (Europe) Ltd. operates as a pharmaceutical firm. The company was founded on March 11, 1994 and is headquartered London, the United Kingdom. | Medical Distributors | Director/Board Member | |
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Ananke Therapeutics, Inc.
Ananke Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ananke Therapeutics, Inc. develops therapeutic medicines for patients. | Pharmaceuticals: Major | Chairman | |
Actio Biosciences, Inc.
Actio Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Actio Biosciences, Inc. is an American precision medicine company that focuses on developing new therapeutics for rare and common diseases by targeting shared genetics. Actio Biosciences was founded in October 2021 and is based in an undisclosed location. The company applies its expertise in genetics, drug discovery, and data sciences to identify programs where both biological and technical risk can be minimized to streamline the drug development process and bring forward potent and precisely targeted therapeutics. The company is led by leaders in genetics and drug development and backed by top healthcare investors. | Pharmaceuticals: Major | Chairman | |
CIRCIO HOLDING ASA | Biotechnology | Director/Board Member | |
Novavax AB
Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
Karolinska Institutet | College/University | Corporate Officer/Principal | |
University of Stockholm | College/University | Undergraduate Degree | |
Verseau Therapeutics, Inc.
Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Verseau Therapeutics, Inc. provides immuno-therapy services. The company was founded by Daniel Anderson, Robert Langer, Igor Feldman, and Tatiana Novobrantseva in 2017 and is headquartered in Bedford, MA. | Miscellaneous Commercial Services | Chairman | |
GE Healthcare Ltd. (United Kingdom)
GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | Corporate Officer/Principal | |
ABLYNX | Biotechnology | Public Communications Contact | |
AURA BIOSCIENCES, INC. | Biotechnology | Chairman | |
SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
SHATTUCK LABS, INC. | Biotechnology | Chairman | |
E-THERAPEUTICS PLC | Biotechnology | Director/Board Member |
Statistiques
Internationale
Royaume-Uni | 24 |
Etats-Unis | 18 |
Suède | 4 |
Belgique | 3 |
Israël | 2 |
Sectorielle
Health Technology | 27 |
Commercial Services | 11 |
Consumer Services | 8 |
Finance | 4 |
Health Services | 2 |
Opérationnelle
Director/Board Member | 192 |
Corporate Officer/Principal | 66 |
Chairman | 34 |
Chief Executive Officer | 25 |
Independent Dir/Board Member | 23 |
Relations les plus connectées
Insiders | |
---|---|
George Golumbeski | 36 |
Samuel Cameron Williams | 27 |
Burt Adelman | 23 |
Jason Lettmann | 21 |
Mario Polywka | 20 |
Andrew Wilson Black | 19 |
Jonathan Hepple | 19 |
Alexander Stevenson | 19 |
Piers John Morgan | 18 |
Alistair Macdonald | 18 |
Eva-Lotta Allan | 17 |
Alexander Fred Markham | 17 |
Elaine Sullivan | 15 |
Harry Finch | 15 |
Timothy Pearson | 15 |